Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal MelanomaRichard D. Carvajal, Gary K. Schwartz, Jose Lutzky et al.|JAMA|2014Cited by 429
Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN InitiativeRobbert S. Puijk, Philippe L. Pereira, Muneeb Ahmed et al.|Radiology|2021Cited by 168
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue SarcomaMrinal M. Gounder, Albiruni Ryan Abdul Razak, Alona Zer et al.|Journal of Clinical Oncology|2016Cited by 165
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, James J. Harding, Madison Darmofal et al.|JCO Precision Oncology|2025Cited by 3